FDA Tells Cedax Maker To Fix Deceptive Marketing
The marketing for Shionogi & Co. Ltd.'s antibiotic Cedax misleads the public by downplaying the drug's risks and overstretching efficacy claims, the U.S. Food and Drug Administration said in a warning...To view the full article, register now.
Already a subscriber? Click here to view full article